Twitter Beğeni Hilesi

Want to know more about the FLASH Mechanical #Thrombectomy Registry? Read the report! jedicath աǟզǟʀ.ǟɦʍɛɖ reviewed the study and talked with Catalin Toma, MD at #TCT2022 👉bit.ly/3R5aEmL #cardiotwitter #cardioed

#ICYMI: Catalin Toma, MD presented #FLASH800 results this week at #TCT2022. Hear more on the topic from C. Michael Gibson MD and Dr. Toma here: bit.ly/3UtQKon #pulmonaryembolism #VTE

Sadly ,#PERT2022 going full virtual due to weather…was looking forward to seeing everyone in person. Plug in for west coast locale next yr :)

St Luke’s Roosevelt medicine residency nostalgia. Countless late “jitney” runs back form StLukes to W59 and 10, this red sign burned into my memory. Every trip back to NYC since staying here …missing a few letters now @LizTemin1 Farah Madhani-Lovely

Catalin Toma, MD discusses PE cardiogenic shock, how it’s a cardiac problem, and ECMO in PE shock, at #SCAISHOCK.

What a crew! Talking #PE and #shock at the annual #SCAISHOCK22 meeting in MSP 🫀🫁 📷: Catalin Toma, MD Mike Jolly Shon Chakrabarti MD MPH Amir Kaki, MD Babar Basir Big thanks to organizers Alex Truesdell Babar Basir and Perwaiz Meraj for having the vision to include #VTE in the shock discussion

Great first European PE conference @EXPERT_PE2022 . Thanks profs Huisman and Erik Klok for the opportunity to present - sole 🇺🇸 presence:) PERT Consortium Inari Medical

Quintessential Pittsburgh

The year in cardiovascular medicine 2022: the top 10 papers in interventional cardiology academic.oup.com/eurheartj/adva…

In this large prospective study in the field of PE, mechanical thrombectomy with the FlowTriever System showed that patients with intermediate- and high-risk PE can be safely treated and derive immediate benefits in haemodynamics, vitals, and symptoms. ow.ly/incH50N2vwQ

Proud to see our TAVR team performing a flawless live Navitor case at CRT2023 congrats Dustin Kliner Ibrahim Sultan Amber Makani UPMC

High risk PE discussion today by Dr. Catalin Toma at #europcr2023 🫁 Case based and a look at pooled data in high risk cohort of #FLASH and the recently released #FLAME study — n = 116, pooled mortality = 0.9% BTW - ❤️ to see a #PE talk at #europcr2023

Is the invasive treatment of pulmonary embolism ready for prime time? Catalin Toma, MD and Andrew SP Sharp discuss procedures, devices & why cardiologists should be involved in the treatment of PE! 📺pcronline.com/Cases-resource… #cardiotwitter #medtwitter

Had the chance of being able to record a PE thrombectomy cases with my partners ⁦Jeff Fowler⁩ ⁦Dustin Kliner⁩ ⁦Michael Bashline⁩ . Unedited live in box case link below. Hopefully some useful info esp for new operators. Thanks ⁦Medinbox⁩ vumedi.com/video/case-cat…

Great concept, but difficult to do with separate catheters. I am still hoping (after pitching this idea to various companies for years...) that we will have a coronary dual lumen IVUS re-entry catheter in the near future Boston Scientific Atul Gupta, MD onlinelibrary.wiley.com/doi/10.1002/cc…

Congratulations to Dr. Catalin Toma, MD, whose paper, "Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism," was recognized at #EuroPCR for best original research! #pulmonaryembolism #PE #thrombectomy

Anybody knows why is Ranger DCB contraindicated in the coronaries? Is there specific data supporting that? Which would be interesting considering it’s essentially the same device as Agent DCB BostonSci Cardiology FDA Medical Devices

Best 90 day Heart Transplant graft survival in the country at #UPMC. Most heart transplants in Pennsylvania. Heart/kidneys, Heart/livers, highly sensitized patients. Incredible outcomes with an incredible team. UPMC Heart and Vascular Institute Pitt Cardiothoracic Surgery Department Pitt Cardiology

Prof Nicolas Meneveau announces the global #PERSEVERE RCT for acute high-risk PE in a full room at #ESCCongress. "PERSEVERE is the first RCT in high-risk PE in 40 years" #FlowTriever #PulmonaryEmbolism #RandomizedTrial #DataMatters #GoldenAge Jay Giri John Moriarty